The Twin Cities metro is home to some of the strongest and largest medical technology and device companies in the nation, ...

The U.S. Food & Drug Administration has approved Johnson & Johnson's device for a type of condition which causes abnormal ...

Becton Dickinson surpassed analysts' expectations for fourth-quarter results on Thursday, helped by strong demand for its ...

The rapidly growing aging population is driving expansion in healthcare, with rising demand for treatments and chronic disease management. Companies like AbbVie (ABBV), Medtronic (MDT), and Centene ...

Minneapolis, Minnesota-based Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies to ...

Medtronic unveils outcomes of the largest multi-centric prospective stroke registry on mechanical thrombectomy in India (PRAAN) ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Globus Medical (GMED – Research Report), ...

About a year ago, renal denervation procedures won a huge victory after finally being greenlit by FDA. Now two of the frontrunners in the space have received reimbursement.

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal ...

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

GE HealthCare Technologies gets a buy rating, agreeing with today's Wall Street and SA analyst consensus. Explore more ...